APA (7th ed.) Citation

Adams, D., Suhr, O., Dyck, P., Litchy, W., Leahy, R., Chen, J., . . . Coelho, T. (2018). Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.

Chicago Style (17th ed.) Citation

Adams, D., O. Suhr, P. Dyck, W. Litchy, R. Leahy, J. Chen, J. Gollob, and T. Coelho. Trial Design and Rationale for APOLLO, a Phase 3, Placebo-controlled Study of Patisiran in Patients with Hereditary ATTR Amyloidosis with Polyneuropathy. 2018.

MLA (8th ed.) Citation

Adams, D., et al. Trial Design and Rationale for APOLLO, a Phase 3, Placebo-controlled Study of Patisiran in Patients with Hereditary ATTR Amyloidosis with Polyneuropathy. 2018.